Type
Rojas-Espinosa O, Arce-Paredes P, Juarez-Ortega M, Hernandez V, Villanueva E, Aguilar-Santelises M. Induction and treatment of anergy in murine leprosy. International journal of experimental pathology [Internet]. 2014;. Available from: http://onlinelibrary.wiley.com/doi/10.1111/iep.12108/epdf
Type
Yang D, Chen J, Shi C, Jing Z, Song N. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Inflammation. 2013;.
Type
Veziris, Chauffour, Escolano, Henquet, Matsuoka. Resistance of M. leprae to Quinolones: A Question of Relativity?. PLOS Neglected Tropical Diseases [Internet]. 2013;. Available from: http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pntd.0002559&representation=PDF
Type
Strengholt. Sexual and reproductive health and rights services for people affected with leprosy or other disabilities. 2013. p. 28 p.
Type
Grzybowski A, Sak J, Pawlikowski J, Iwanowicz-Palus G. Gerhard Henrik Armauer Hansen (1841-1912)--the 100th anniversary of the death of the discoverer of Mycobacterium leprae. Clinics in dermatology. 2013;31(5):653-55.
Type
Kumar S, Naqvi RA, Ali R, Rani R, Khanna N, Rao. FoxP3 provides competitive fitness to CD4(+) CD25(+) T cells in leprosy patients via transcriptional regulation. European journal of immunology. 2013;.
Type
Saunderson. Editor’s choice – September 2013. Leprosy review. 2013;84(3):175.
Type
KUSAKA. Alteration in the lipid content of the blood and tissues in leprosy patients. Repura. 1958;27:5 p.
Type
Chaitanya, Lavania, Nigam, Turankar, Singh, Horo, et al. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy. Immunology letters. 2013;156(1-2):159-67.
Type
Kumar, Girdhar, Girdhar. Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study. Indian Journal of Medical Research [Internet]. 2013;38:536-540. Available from: http://icmr.nic.in/ijmr/2013/october/1011.pdf